Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and subsequent disposal of Class A Common Stock to cover tax obligations.
Summary
- On June 8, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, engaged in transactions involving Class A Common Stock.
- These transactions included the vesting of restricted stock units (RSUs) and the subsequent disposal of shares to satisfy tax withholding obligations.
- Specifically, 10,201 and 2,232 shares vested from two separate restricted stock unit awards.
- Following the vesting, 3,640 and 797 shares were disposed of at a price of $8.55 to cover tax liabilities.
- After these transactions, Nabiey directly owns 133,813 shares of Class A Common Stock.
- Nabiey also holds 91,807 and 33,484 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive stock transactions, and does not inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, and is typical for publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 12/08/2022 | Initial vesting date for one of the restricted stock unit awards. |
| 06/08/2024 | Date of the reported transactions, including vesting of RSUs and disposal of shares for tax obligations. |
| 06/10/2024 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.